• Version
• Download 2992
• File Size 239.12 KB
• File Count 1
• Create Date February 9, 2022
• Last Updated February 15, 2022

Parallel Importation Rules 2019

Recently, the Pharmacy and Poisons Board of Kenya made a bold decision to address what may be the local pharmaceutical industry’s most controversial issue, parallel trade in pharmaceuticals. While there have been previous attempts to tackle this matter in the past, it is hoped that the current attempt will pay attention to all important aspects of this issue in order to build a consensus among all interested parties in coming up with a policy position that is not only widely accepted but also addresses most of the contentious issues once and for all.  Through a process considered largely as inclusive, the exercise commenced with the PPB organizing a stakeholders’ forum where issues of parallel import of pharmaceuticals were deliberated upon; the outputs of these discussions were subjected to a focused/technical committee consisting mainly of representatives from the following interest groups among other membership: Kenya Association of Pharmaceutical Industry (KAPI), Kenya Association of Pharmaceutic Distributors (KAPD) and the representatives from the regulator, the Pharmacy and Poisons Board of Kenya.

The result is the current product, a draft regulation framework, and the rules 2019.

Attached Files